Molnupiravir; molecular and functional descriptors of mitochondrial safety

Molnupiravir is an orally active nucleoside analog antiviral drug that recently was approved by the U.S. FDA for emergency treatment of adult patients infected with the SARS-CoV-2 (COVID-19) virus and at risk for severe progression. The active form of the drug, N-hydroxycytidine (NHC) triphosphate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallace, K.B., Bjork, J.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958731/
https://www.ncbi.nlm.nih.gov/pubmed/35358570
http://dx.doi.org/10.1016/j.taap.2022.116003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958731/
https://www.ncbi.nlm.nih.gov/pubmed/35358570
http://dx.doi.org/10.1016/j.taap.2022.116003

Ejemplares similares